SP Tulsian cautious on Sun Pharma

Sep 24, 2013, 05.51 PM IST

SP Tulsian of sptulsian.com has a cautious view on Sun Pharmaceutical Industries. "If one takes the market cap, probably this is the most expensive stock," he adds.

Like this story, share it with millions of investors on M3

SP Tulsian cautious on Sun Pharma

SP Tulsian of sptulsian.com has a cautious view on Sun Pharmaceutical Industries. "If one takes the market cap, probably this is the most expensive stock," he adds.

Like this story, share it with millions of investors on M3

SP Tulsian cautious on Sun Pharma

SP Tulsian of sptulsian.com has a cautious view on Sun Pharmaceutical Industries. "If one takes the market cap, probably this is the most expensive stock," he adds.

  .   Share  .  Email  .  Print  .  A+A-

SP Tulsian of sptulsian.com told CNBC-TV18, "I have been keeping my cautious stance on Sun Pharmaceutical Industries . For last may be couple of months it has not been able to breach beyond Rs 560 and it again corrects to a level of Rs 515-520. So, probably this has become a trading stock in that broad band. If one takes the market cap, probably this is the most expensive stock.

"I think that people have started shifting their focus to the other promising pharma stocks and that is the reason the focus has shifted from Sun Pharma and I will be keeping my cautious stance on the stock," he said.

Also Read: Sun Pharma gets US FDA nod for Prevacid generic drug

HEALTHCARE: Future of Healthcare

Anda sedang membaca artikel tentang

SP Tulsian cautious on Sun Pharma

Dengan url

http://harmonisem.blogspot.com/2013/09/sp-tulsian-cautious-on-sun-pharma.html?m=0

Anda boleh menyebar luaskannya atau mengcopy paste-nya

SP Tulsian cautious on Sun Pharma

namun jangan lupa untuk meletakkan link

SP Tulsian cautious on Sun Pharma

sebagai sumbernya